Trials / Completed
CompletedNCT02752958
Impact of Long Term Management of Dentine Hypersensitivity (DH) With a Daily Use Anti-sensitivity Toothpaste on the Quality of Life Related to Oral Health
Study to Investigate the Impact on Oral Health Related Quality of Life of Managing Dentine Hypersensitivity With a Daily Use Anti-Sensitivity Toothpaste
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This multicentre, non-comparative design study will monitor the impact of long term management of DH with daily use of a sensitivity toothpaste on the quality of life of a population of sensitivity sufferers. Changes in oral health related quality of life will be monitored using the Dentine Hypersensitivity Experience Questionnaire (DHEQ). The study will be conducted in participants in good general health, with pre-existing self-reported and clinically diagnosed tooth sensitivity at screening.
Detailed description
This will be multicenter, non-comparative design to monitor the impact of long term management of DH with daily use of a sensitivity toothpaste on the quality of life of a population of sensitivity sufferers, using the DHEQ. Changes in DH will be monitored clinically over the 24 week treatment period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | stannous fluoride | 0.454% w/w (weight per weight) stannous fluoride |
Timeline
- Start date
- 2016-05-23
- Primary completion
- 2017-02-01
- Completion
- 2017-02-03
- First posted
- 2016-04-27
- Last updated
- 2018-08-27
- Results posted
- 2018-08-27
Locations
2 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02752958. Inclusion in this directory is not an endorsement.